Intervention targeting the HMGB1/TLR4/NF-κB pathway could alleviate neuroinflammation and improve cognitive impairment in models of depression, cognitive impairment caused by high-fat and high-sugar diets, and traumatic brain injury [57,60,61,62]. Here, HMGB1 is linked to depressive symptom measurement.